Dudley Robert Michael - Insider Non-Derivative Transactions at Transcode Therapeutics, Inc. (RNAZ) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 28, 2023, Dudley Robert Michael's relationship to Transcode Therapeutics, Inc. (RNAZ) is Director,Officer (Chief Executive Officer), and currently has 180,262 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RNAZ insiders.
Data Source: SEC.
Dudley Robert Michael - Insider Non-Derivative Transactions of RNAZ Common Stock
Dudley Robert Michael - Insider Non-Derivative Transactions at RNAZ
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 29, 2023 | P -- (Common Stock) | 98000 | 0.51 | 180262 |
| Jun 22, 2023 | P -- (Common Stock) | 12000 | 2.65 | 82262 |
| Jun 21, 2023 | P -- (Common Stock) | 6607 | 2.55 | 70262 |
| Jun 10, 2023 | P -- (Common Stock) | 19000 | 2.76 | 61155 |
| Jun 10, 2023 | P -- (Common Stock) | 19000 | 2.76 | 912114 |